<?xml version="1.0" encoding="UTF-8"?>
<list list-type="order">
 <list-item>
  <p>Randomized controlled trials (RCTs) and cohort clinical trials (CCTs) in which the intervention was antiviral therapy (IFN or NAs) were included. All studies had a follow-up period of at least 6 months and had been published in a journal.</p>
 </list-item>
 <list-item>
  <p>All included patients were diagnosed histologically based on the existence of HBeAg, HBcAg, or HBV-DNA in renal biopsy specimens, accompanied with HBV surface antigen (HBsAg)-positive serum and were free from lupus nephritis and other secondary glomerular diseases[
   <xref rid="pone.0227532.ref013" ref-type="bibr">13</xref>].
  </p>
 </list-item>
</list>
